InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Herskowitz Neil, Director. Officer active across 4 companies, notably Avenue Therapeutics, INC.. Cumulatively, 10 reports have been published. Total volume traded: €17k. The latest transaction was filed on 16 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations10 total
047,619 shares0
COMMON STOCK
SEC:0001104659-22-074467:0·
030,000 shares0
COMMON STOCK
SEC:0001104659-22-042276:0·
049,020 shares0
Common Stock
SEC:0001104659-21-152198·
049,020 shares0
Common Stock
SEC:0001104659-21-152198:0·
013,774 shares0
COMMON STOCK
SEC:0001104659-21-090240·
013,774 shares0
COMMON STOCK
SEC:0001104659-21-090240:0·
016,502 shares0
COMMON STOCK
SEC:0001104659-21-080361:0·
016,502 shares0
COMMON STOCK
SEC:0001104659-21-080361·
€8,2652,500 shares@ €3.3061100.0% of flow
Common Stock
SEC:0001104659-21-062774·
Ideal exit: 31 Jan 2022 (T+270)
€8,2652,500 shares@ €3.30610.38% mcap50.0% of flow
Common Stock
SEC:0001104659-21-062774:0·
Ideal exit: 31 Jan 2022 (T+270)
10 of 10 declarations
About Herskowitz Neil
Neil Herskowitz is a Board Member at Avenue Therapeutics, Inc., Checkpoint Therapeutics, Inc., and Mustang Bio, Inc. As a board member, he contributes to the governance and strategic direction of these companies. Neil brings his expertise to help guide strategic decisions and ensure compliance with regulations.
